These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8526781)

  • 21. [Dynamics of the formation of the primary and secondary products of lipid peroxidation in copper dependent oxidation of the blood serum low density lipoproteins in patients with myocardial ischemia].
    Azizova OA; Vakhrusheva TN; Dremina ES; Sharov VS; Perova NV; Ozerova IN; Mazaev VP
    Biull Eksp Biol Med; 1996 Jul; 122(7):32-6. PubMed ID: 9303694
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins.
    Mahley RW; Can S; Ozbayrakçi S; Bersot TP; Tanir S; Palaoğlu KE; Pépin GM
    Am J Cardiol; 2005 Aug; 96(4):547-55. PubMed ID: 16098310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updating of hygiene standards for carbon disulfide based on health risk assessment.
    Stetkiewicz J; Wrońska-Nofer T
    Int J Occup Med Environ Health; 1998; 11(2):129-43. PubMed ID: 9753892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coronary heart disease and occupational exposure to carbon disulphide].
    Hernberg S
    Duodecim; 1975; 91(8):501-3. PubMed ID: 1140121
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial.
    Zhao XQ; Kosinski AS; Barnhart HX; Superko HR; King SB
    Med Sci Monit; 2003 Feb; 9(2):CR48-54. PubMed ID: 12601286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men.
    Cordero A; Andrés E; Ordoñez B; León M; Laclaustra M; Grima A; Luengo E; Moreno J; Bes M; Pascual I; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Am J Cardiol; 2009 Nov; 104(10):1393-7. PubMed ID: 19892056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of the hearing system in workers chronically exposed to carbon disulfide and noise].
    Kowalska S; Sułkowski W; Sińczuk-Walczak H
    Med Pr; 2000; 51(2):123-38. PubMed ID: 10971926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipid lowering treatment in secondary prevention following myocardial infarct].
    Paragh G; Balogh Z; Boda J; Mohácsi A; Kovács P; Polgár P; Wórum F; Kakuk G
    Orv Hetil; 1997 Jul; 138(29):1849-53. PubMed ID: 9280882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rheumatoid arthritis--a risk factor of ischemic heart disease].
    Hollan I; Mikkelsen K; Førre Ø
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3259-62. PubMed ID: 16327849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease.
    Kress JP; Vinayak AG; Levitt J; Schweickert WD; Gehlbach BK; Zimmerman F; Pohlman AS; Hall JB
    Crit Care Med; 2007 Feb; 35(2):365-71. PubMed ID: 17205005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
    Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationships between intravascular ultrasonographic findings and coronary risk factors in patients with normal coronary angiography].
    Noike H; Hitsumoto T; Sakurai T; Sugiyama Y; Sato S; Iizuka T; Takahashi M; Shimizu K; Nakamura K; Ohsawa H
    J Cardiol; 2005 Jan; 45(1):1-10. PubMed ID: 15700924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and coronary artery disease: mechanistic insights and therapeutic challenges.
    Narkiewicz K; Kjeldsen SE; Hedner T
    Blood Press; 2005; 14(5):260-1. PubMed ID: 16257869
    [No Abstract]   [Full Text] [Related]  

  • 35. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease.
    Moore M
    J Insur Med; 1998; 30(2):111-2. PubMed ID: 10339292
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coronary risk factors and mode of ischemic heart disease treatment in patients over 65 years of age].
    Chizyński K
    Przegl Lek; 2003; 60(7):451-5. PubMed ID: 14750417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Styrene exposure and ischemic heart disease: a case-cohort study.
    Matanoski GM; Tao XG
    Am J Epidemiol; 2003 Nov; 158(10):988-95. PubMed ID: 14607807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis?
    Mehta JL
    J Am Coll Cardiol; 2006 Sep; 48(5):980-2. PubMed ID: 16949490
    [No Abstract]   [Full Text] [Related]  

  • 39. Obstructive sleep apnea and coronary artery disease.
    Lüthje L; Andreas S
    Sleep Med Rev; 2008 Feb; 12(1):19-31. PubMed ID: 17936040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Accidents caused by carbon disulfide and carbon tetrachloride].
    Bouletreau P; Motin J; Vincent V
    Rev Prat; 1965 Nov; 15(29):3805-12. PubMed ID: 5841956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.